Stem Cells Spin (WAR:SCS) FCF Margin %: -785.71% (As of Mar. 2026)

What is Stem Cells Spin FCF Margin %?

Stem Cells Spin WAR:SCS 25 FCF Margin % is -785.71% as of Mar. 2026. GuruFocus rates WAR:SCS with a GF Score™ of 25/100 and a GF Value™ of zł0.10 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 954 Biotechnology companies, Stem Cells Spin ranks worse than 58.6% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Stem Cells Spin's Free Cash Flow for the three months ended in Mar. 2026 was zł-0.06 Mil. Stem Cells Spin's Revenue for the three months ended in Mar. 2026 was zł0.01 Mil. Therefore, Stem Cells Spin's FCF Margin % for the quarter that ended in Mar. 2026 was -785.71%.

As of today, Stem Cells Spin's current FCF Yield % is -0.65%.

The historical rank and industry rank for Stem Cells Spin's FCF Margin % or its related term are showing as below:

WAR:SCS' s FCF Margin % Range Over the Past 10 Years
Min: -241.13 Med: 0.61 Max: 125.29
Current: -164.62

During the past 13 years, the highest FCF Margin % of Stem Cells Spin was 125.29%. The lowest was -241.13%. And the median was 0.61%.

WAR:SCS's FCF Margin % is ranked worse than
58.6% of 954 companies
in the Biotechnology industry
Industry Median: -84.535 vs WAR:SCS: -164.62

Stem Cells Spin FCF Margin % Related Terms

Stem Cells Spin FCF Margin % Historical Data

* Premium members only.

The historical data trend for Stem Cells Spin's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stem Cells Spin FCF Margin % Chart

Stem Cells Spin Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

FCF Margin %

Get a 7-Day Free Trial

125.29

-241.13

22.43

79.63

-130.30

Stem Cells Spin Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
FCF Margin %	Get a 7-Day Free Trial															-437.50	-128.00	-84.85	0.00	-785.71

WAR:SCS vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Stem Cells Spin's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stem Cells Spin FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Stem Cells Spin's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Stem Cells Spin's FCF Margin % falls into.

Save Embed

25GF Score

Stem Cells Spin SA WAR:SCS

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Stem Cells Spin FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Stem Cells Spin's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-0.086	/	0.066
	=	-130.30 %

Stem Cells Spin's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-0.055	/	0.007
	=	-785.71 %

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of -785.71% mean?

Stem Cells Spin (WAR:SCS) has a FCF Margin % of -785.71% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Stem Cells Spin and its competitors. According to the industry distribution chart, Stem Cells Spin ranks #559 out of 954 companies in the Biotechnology industry, placing it in the top 58.6%.

Is Stem Cells Spin's FCF Margin % too high?

Stem Cells Spin's current FCF Margin % is -785.71%. Based on the distribution chart, Stem Cells Spin ranks #559 out of 954 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Stem Cells Spin has a GF Score™ of 25/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Stem Cells Spin's FCF Margin % compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, Stem Cells Spin ranks #559 out of 954 companies for FCF Margin %. This places Stem Cells Spin in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Biotechnology company?

A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Stem Cells Spin and its competitors. Stem Cells Spin's current FCF Margin % is -785.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Stem Cells Spin stock overvalued right now?

Based on GuruFocus' analysis, Stem Cells Spin (WAR:SCS) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.10, compared to a current price of zł0.40 — trading 300% above its estimated fair value. The current FCF Margin % is -785.71%. Stem Cells Spin's overall GF Score™ is 25/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For Stem Cells Spin (WAR:SCS), the current FCF Margin % is -785.71% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stem Cells Spin (WAR:SCS) Overvalued in 2026?

Based on GuruFocus' analysis, Stem Cells Spin stock appears to be overvalued. The current stock price of zł0.40 is trading 300% above its estimated GF Value™ of zł0.10. GuruFocus considers Stem Cells Spin to be Significantly Overvalued.

Key valuation signals for WAR:SCS:

FCF Margin %: -785.71%
GF Value™: zł0.10 vs. price of zł0.40 (300% above fair value)
GF Score™: 25/100 with 3 warning signs

No single metric tells the full story. See the WAR:SCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stem Cells Spin Business Description

Industry Healthcare Biotechnology

Comparable Companies WAR:GX1 WAR:PUR WAR:PHR WAR:RDG WAR:URT VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA XKRX:068270 RPRX ROIV BNTX INCY

Address Ulica Konopnickiej 15 b, Wroclaw, POL, 51-141

Website https://www.stemcellsspin.com

Stem Cells Spin SA is a biotechnology company. The company is engaged in the development, production, marketing, and sale of natural regenerative products for the dermocosmetic and veterinary care markets, as well as applications for the human and veterinary medical industry. Its products include NHAC Biocervin MIC-1, Revitacell, PRS MIC-1, and Velvetyna.

25GF Score

Get the complete analysis for WAR:SCS

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.40

Price

zł0.10

GF Value

View WAR:SCS Analysis

See FCF Margin % data for all stocks →